Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia

2009 ◽  
Vol 81 (8) ◽  
pp. 1348-1353 ◽  
Author(s):  
Tatjana Vilibic Cavlek ◽  
Ira Gjenero Margan ◽  
Snjezana Zidovec Lepej ◽  
Branko Kolaric ◽  
Adriana Vince
2020 ◽  
Vol 24 (4) ◽  
pp. 304-309 ◽  
Author(s):  
Geison Luiz Costa de Castro ◽  
Ednelza da Graça Silva Amoras ◽  
Mauro Sérgio Moura de Araújo ◽  
Simone Regina Souza da Silva Conde ◽  
Antonio Carlos R. Vallinoto

2018 ◽  
Vol 11 (12) ◽  
Author(s):  
Fahimeh Ranjbar Kermani ◽  
Sedigheh Amini-Kafiabad ◽  
Kamran Mousavi Hosseini ◽  
Mahtab Maghsudlu ◽  
Zohreh Sharifi ◽  
...  

Intervirology ◽  
2014 ◽  
Vol 57 (6) ◽  
pp. 311-318 ◽  
Author(s):  
Arnolfo Petruzziello ◽  
Nicola Coppola ◽  
Giovanna Loquercio ◽  
Samantha Marigliano ◽  
Margherita Giordano ◽  
...  

2017 ◽  
Vol 18 (2) ◽  
pp. 114-117 ◽  
Author(s):  
Antoine Abou Rached ◽  
Cesar Yaghi ◽  
Leda Khalil ◽  
Jowana Saba ◽  
Walid Ammar

2015 ◽  
Vol 4 (1) ◽  
pp. 6-9
Author(s):  
Chao Meng ◽  
Na Li ◽  
Zhaoxiao Tong ◽  
Huangxin Yan ◽  
Shenxiao Min

Abstract Viral hepatitis C is one of the most prevalent infectious diseases in the world and may cause serious hepatic diseases in the future. Hepatitis C-infected people account for approximately 2% to 3% of the world’s population. The main causes of hepatitis C infection in developing countries are unsafe medical injection and contaminated blood and blood products; whereas in developed countries, it is mainly caused by injection, drug abuse, and high-risk sexual behavior. The focus of hepatitis C prevention and control should be placed on safer blood supply, safer health care and related unnecessary injection, reduction of injection drug use, and high-risk sexual behavior because effective vaccine and postexposure prophylaxis are not yet available.


Sign in / Sign up

Export Citation Format

Share Document